Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>Yixin launched its IPO on Monday and plans a swift closing by Thursday, targeting to raise up to USD867m. In this insight, we will look at company fundamentals, industry background and how it benefits from its strong shareholder backing. We will also score the deal in our ECM Framework.</p><div><h2>Deal and framework score overview</h2></div><p>The embed below is from our IPO tool, which has been designed to provide you with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up…</p>

Yixin launched its IPO on Monday and plans a swift closing by Thursday, targeting to raise up to USD867m. In this insight, we will look at company fundamentals, industry background and how it benefits from its strong shareholder backing. We will also score the deal in our ECM Framework.Deal and framework score overviewThe embed below is from our IPO tool, which has been designed to provide you with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up…

Yixin IPO: Strong Shareholder Backing/Growth/Sentiment

China

Yixin Group Limited offers an online automobile finance transaction platform. The Company provides loan facilitation, car rental, and other services. Yixin Group operates in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Yixin Group (2858 HK)

Yixin IPO: Strong Shareholder Backing/Growth/Sentiment

Yixin launched its IPO on Monday and plans a swift closing by Thursday, targeting to raise up to USD867m. In this insight, we will look at company...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)